-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Annovis Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Annovis Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.39M, a 70.5% increase year-over-year.
- Annovis Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$30.4M, a 28.3% increase year-over-year.
- Annovis Bio, Inc. annual Operating Income (Loss) for 2023 was -$45M, a 76.5% decline from 2022.
- Annovis Bio, Inc. annual Operating Income (Loss) for 2022 was -$25.5M, a 75.5% decline from 2021.
- Annovis Bio, Inc. annual Operating Income (Loss) for 2021 was -$14.5M, a 119% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)